Sign Up to like & get
recommendations!
2
Published in 2023 at "ACS Omega"
DOI: 10.1021/acsomega.3c00400
Abstract: Most biopharmaceutics classification system (BCS) class IV drugs have limited oral bioavailability due to poor solubility and poorer permeability. This work aims to investigate the possibility of utilizing disulfide bridged nanoparticles to improve BCS IV…
read more here.
Keywords:
bridged nanoparticles;
sodium alginate;
ptl;
thiolated sodium ... See more keywords